Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,549 | 52 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,290 | 37 | $0 (2022) |
| ABBVIE INC. | $42.79 | 3 | $0 (2023) |
| Exact Sciences Corporation | $37.42 | 2 | $0 (2023) |
| Lilly USA, LLC | $23.15 | 1 | $0 (2024) |
| Almatica Pharma LLC | $22.12 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $21.01 | 1 | $0 (2022) |
| Abbott Laboratories | $18.24 | 1 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $18.14 | 1 | $0 (2022) |
| Dexcom, Inc. | $17.03 | 1 | $0 (2022) |
| Phadia US Inc. | $16.71 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.15 | 1 | Lilly USA, LLC ($23.15) |
| 2023 | $108.23 | 6 | Exact Sciences Corporation ($37.42) |
| 2022 | $478.34 | 14 | Novo Nordisk Inc ($408.60) |
| 2021 | $939.73 | 31 | Novo Nordisk Inc ($881.48) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/13/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Obesity | ||||||
| 09/01/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Oncology | ||||||
| 06/15/2023 | Almatica Pharma LLC | SERTRALINE HCL (Drug), LOREEV XR, GRALISE | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: ANTI-DEPRESSION | ||||||
| 06/02/2023 | Merck Sharp & Dohme LLC | PNEUMOVAX 23 (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: VACCINE | ||||||
| 05/10/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Neuromodulation | ||||||
| 04/20/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Oncology | ||||||
| 01/19/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: PRIMARY CARE | ||||||
| 05/25/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Endocrinology | ||||||
| 05/23/2022 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: CNS | ||||||
| 05/19/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Diabetes | ||||||
| 05/11/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: Diabetes | ||||||
| 04/12/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/06/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.69 | General |
| Category: Diabetes | ||||||
| 04/01/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: Diabetes | ||||||
| 03/17/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $118.00 | General |
| Category: Diabetes | ||||||
| 03/10/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Diabetes | ||||||
| 02/17/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $115.49 | General |
| Category: Diabetes | ||||||
| 02/17/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: Diabetes | ||||||
| 02/04/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.61 | General |
| Category: Diabetes | ||||||
| 01/18/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: Diabetes | ||||||
| 12/16/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 12/15/2021 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $16.71 | General |
| Category: Allergy/Immunology | ||||||
| 11/16/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $3.83 | General |
| Category: Diabetes | ||||||
| 11/05/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.02 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 208 | 273 | $33,993 | $12,188 |
| 2022 | 3 | 38 | 48 | $6,690 | $2,540 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 115 | $14,950 | $4,588 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 62 | $9,920 | $3,151 | 31.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $4,160 | $3,068 | 73.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 23 | 31 | $4,030 | $1,113 | 27.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 22 | 22 | $440.00 | $177.76 | 40.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 17 | 17 | $493.00 | $91.20 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 15 | $2,400 | $976.92 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 20 | $2,600 | $948.40 | 36.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 13 | $1,690 | $614.38 | 36.4% |
About Ashley Netrow
Ashley Netrow is a Nurse Practitioner healthcare provider based in Ojai, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2019. The National Provider Identifier (NPI) number assigned to this provider is 1467926725.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Netrow has received a total of $1,549 in payments from pharmaceutical and medical device companies, with $23.15 received in 2024. These payments were reported across 52 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,549).
As a Medicare-enrolled provider, Netrow has provided services to 246 Medicare beneficiaries, totaling 321 services with total Medicare billing of $14,728. Data is available for 2 years (2022–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Ojai, CA
- Active Since 01/18/2019
- Last Updated 04/10/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1467926725
Products in Payments
- Ozempic (Drug) $576.18
- RYBELSUS (Drug) $467.84
- Rybelsus (Drug) $242.98
- Cologuard Collection Kit (Device) $37.42
- HUMIRA (Biological) $28.78
- ZEPBOUND (Drug) $23.15
- SERTRALINE HCL (Drug) $22.12
- ENTRESTO (Drug) $21.01
- PROCLAIM (Device) $18.24
- NURTEC ODT (Drug) $18.14
- Dexcom G6 Transmitter (Medical Supply) $17.03
- ImmunoCAP (Device) $16.71
- PNEUMOVAX 23 (Biological) $16.44
- UBRELVY (Drug) $14.01
- VIVITROL (Drug) $13.56
- Linzess (Drug) $12.76
- REBINYN (Biological) $3.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.